In the year since the launch of the AllTrials campaign over 63,000 people have signed the petition and 445 organisations have joined up; MEPs told us that our supporters’ input shaped the new European clinical trials law; and companies, research funders and regulators are having serious discussions about how to implement necessary changes to increase transparency.

This is great progress, but transparency in clinical trials is a global issue and to effect a major and lasting change the campaign has to have success internationally. There are people around the world who want to build the campaign in their own country and we want to help them by producing material they can use.

We launched an appeal for donations in October 2013 to make a short campaign video that gathers together the voices of patients, doctors, campaigners and pharmaceutical companies. You helped us reach our target and we’ve started filming with Rob Frost, Policy Director from the Chief Medical Officers office at GSK; Dr Ben Goldacre, doctor and author; Richard Stephens, cancer patient and trial participant; and Síle Lane, who manages campaigns at Sense about Science and runs AllTrials.

We hope the video will be ready in a few weeks and will be subtitled in many languages to maximise its reach.  Thank you to everyone who kindly fundraised for us or donated money to the appeal. We hope you will share the video with your contacts and networks when it’s launched and help us spread the word far and wide.

Here’s a sneak preview from behind the scenes:


Ben GoldacreBen Goldacre explains why doctors must have access to all trial results


Sile Lane Síle Lane talks about the importance of publishing all trials, past and present


The team from Red Banana Ltd with Richard Stephens and Sile LaneThe team from Red Banana Ltd with Síle and Richard Stephens
after relating his own experiences with clinical trials


Rob FrostRob Frost explains why GSK joined AllTrials and the importance of transparancy